Wed, Apr 17, 2024
According to ICICI Securities, these stocks can help investors get a return of up to 28 per cent in the next one year.
More >
Tue, Apr 16, 2024
The acquisition will include Ivia Beaute's brands namely Astaberry, Ikin and Bhimsaini on a worldwide basis, the company said.
Wed, Mar 27, 2024
Sanofi India share price, Cipla share price: Shares of pharmaceutical companies Sanofi India and Cipla gained on Wednesday, March 27, after the firms announced an exclusive distribution tie-up for expanding the reach of Sanofi’s Central Nervous System (CNS) portfolio, including its six brands.
Thu, Jan 27, 2022
Brokerage house ICICI Securities and HDFC securities have maintained buy rating on Cipla despite the pharma major witnessed marginal decline in net profit.
Indian market is likely to retest crucial support levels on Thursday, tracking weak global cues
Wed, Jan 26, 2022
Drug major Cipla on Wednesday said Naina Lal Kidwai has resigned as independent director on its board, with effect from March 31, 2022
Tue, Jan 25, 2022
Most of the analysts had estimated that the profit would show a dip year-on-year YoY, and revenue may jump marginally by around 2 per cent.
Mon, Jan 24, 2022
The pharmaceutical major Cipla is likely to report muted third quarter earnings for the financial year 2021-22, most of the brokerage houses and analysts predict in their results preview.
The Indian markets are likely to witness some volatility on Monday tracking weak global cues, but there will be stock-specific action in which global brokerage came out with their reports on business development, or earnings outlook.
Wed, Dec 29, 2021
The rise of the Covid-19 variant Omicron has once again brought pharma shares in focus.
Mon, Dec 27, 2021
Spotlight was on Nifty Pharma as the index was the top gainer around this time. It was trading at 13,710.80 and near its intraday high, up 1.6 per cent from the Friday closing level
Sun, Dec 19, 2021
Drug major Cipla on Sunday said it has received approval from the US health regulator to market the Lanreotide injection, used for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumors, in the American market
Fri, Nov 26, 2021
As the bears grip the market during Friday’s session, metal, auto, and pharma stocks witnessed a maximum buzz. In this regard, JSW Steel, Tata Motors, Hindalco slipped most, while Cipla and Dr Reddy’s were the top gainers in the otherwise negative market.
Tue, Oct 26, 2021
Drug major Cipla on Tuesday said its consolidated profit after tax (PAT) rose by 7 per cent to Rs 711 crore for the second quarter ending September, aided by strong performance in the domestic as well as international markets.
Thu, Sep 30, 2021
Cardiovascular disease (CVD) is the leading cause of mortality and accounts for one-third of global deaths. Cardiac has displaced anti-infectives as the leading therapy in the India Pharma Market (IPM).
Wed, Sep 29, 2021
Sun Pharmaceuticals – The shares of Sun Pharma today ended at Rs 790.50 on Tuesday, up 3.6 per cent from the Monday closing price. He puts target price at Rs 850-Rs 880 with a stop loss at Rs 755. The stock has seen some correction after attaining a 52-week high of Rs 804.35 on 3 August
Sun, Sep 19, 2021
Sandeep Jain recommends Cipla as an intraday pick on Monday. This is from the F&O segment. This stock was recommended at Rs 954. He puts the target price at Rs 965 while the stop loss at Rs 947
Thu, Aug 12, 2021
Drug firm Cipla has received approval from the US health regulator to market Difluprednate Ophthalmic Emulsion in the American market.
Wed, Jun 30, 2021
As Drugs Controller General of India (DCGI) allowed Cipla to import Moderna’s Covid-19 vaccine, the shares of the pharma major hit a new 52-week high of Rs 997.20 after rallying almost two per cent on the BSE intraday trade on Wednesday. The stock has surged around four per cent since Monday.
Tue, Jun 29, 2021
Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik.
Stock Markets ended in the red on Tuesday. The BSE Sensex closed at 52,567.30 today, down by over 168 points or 0.3 per cent. Meanwhile, the broader Market NSE Nifty 50 ended at 15,748.45, down by 66 points or 0.4 per cent
Sun, Jun 20, 2021
The stock markets on Friday traded with high volatility. The markets opened without much noise and then fell steeply. Nifty 50 had a free fall and touching around levels of 15,450 on the intraday basis which was a crucial level. The previous lifetime was 15,431 and the markets took a support at this level. Market Analyst Sandeep Jain said that last trading session of the week was extremely action packed.
Thu, May 20, 2021
Cipla share price: Sharekhan expects Cipla’s topline and PAT to report a CAGR of 11.9% and 23.8%, respectively, over FY2021-FY2023E.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.